XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Treasury stock
Retained Earnings
Beginning balance at Apr. 30, 2022 $ 913.8   $ 19.2 $ 169.0 $ (26.8) $ (11.5) $ 763.9
Beginning balance (in shares) at Apr. 30, 2022     38,276,968        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (0.4)           (0.4)
Issuance of restricted stock, net of tax withholding (in shares)     63,643        
Exercise of stock options 1.5     1.5      
Exercise of stock options (in shares)     40,000        
Purchases of common stock $ (39.6)   $ (0.6)       (39.0)
Purchases of common stock (in shares) (1,005,514)   (1,005,514)        
Stock-based compensation expense $ 8.4     8.4      
Other comprehensive income (loss) 5.2       5.2    
Net (loss) income 69.0           69.0
Dividends on common stock (15.3)           (15.3)
Ending balance at Jan. 28, 2023 942.6   $ 18.6 178.9 (21.6) (11.5) 778.2
Ending balance (in shares) at Jan. 28, 2023     37,375,097        
Beginning balance at Oct. 29, 2022 898.8   $ 18.7 174.7 (54.3) (11.5) 771.2
Beginning balance (in shares) at Oct. 29, 2022     37,505,633        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (in shares)     9,164        
Exercise of stock options 1.5     1.5      
Exercise of stock options (in shares)     40,000        
Purchases of common stock $ (8.0)   $ (0.1)       (7.9)
Purchases of common stock (in shares) (179,700)   (179,700)        
Stock-based compensation expense $ 2.7     2.7      
Other comprehensive income (loss) 32.7       32.7    
Net (loss) income 19.9           19.9
Dividends on common stock (5.0)           (5.0)
Ending balance at Jan. 28, 2023 942.6   $ 18.6 178.9 (21.6) (11.5) 778.2
Ending balance (in shares) at Jan. 28, 2023     37,375,097        
Beginning balance at Apr. 29, 2023 941.8   $ 18.6 181.0 (19.0) (11.5) 772.7
Beginning Balance at Apr. 29, 2023   $ 11.1          
Beginning balance (in shares) at Apr. 29, 2023     37,167,375        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (3.8)   $ 0.1 (0.1)     (3.8)
Issuance of restricted stock, net of tax withholding (in shares)     255,120        
Cancellation of restricted stock     $ (0.1) 0.1      
Cancellation of restricted stock (in shares)     (144,000)        
Purchase of redeemable noncontrolling interest   $ (11.1)          
Purchases of common stock $ (10.8)   $ (0.2)       (10.6)
Purchases of common stock (in shares) (453,371)   (453,371)        
Stock-based compensation expense $ 0.7     0.7      
Other comprehensive income (loss) (12.2)       (12.2)    
Net (loss) income (66.0)           (66.0)
Dividends on common stock (14.7)           (14.7)
Ending balance at Jan. 27, 2024 835.0   $ 18.4 181.7 (31.2) (11.5) 677.6
Ending balance (in shares) at Jan. 27, 2024     36,825,124        
Beginning balance at Oct. 28, 2023 844.9   $ 18.5 183.8 (42.9) (11.5) 697.0
Beginning balance (in shares) at Oct. 28, 2023     37,034,050        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock, net of tax withholding (in shares)     65,666        
Cancellation of restricted stock     $ (0.1) 0.1      
Cancellation of restricted stock (in shares)     (144,000)        
Purchases of common stock $ (3.0)           (3.0)
Purchases of common stock (in shares) (130,592)   (130,592)        
Stock-based compensation expense $ (2.2)     (2.2)      
Other comprehensive income (loss) 11.7       11.7    
Net (loss) income (11.6)           (11.6)
Dividends on common stock (4.8)           (4.8)
Ending balance at Jan. 27, 2024 $ 835.0   $ 18.4 $ 181.7 $ (31.2) $ (11.5) $ 677.6
Ending balance (in shares) at Jan. 27, 2024     36,825,124